本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CALIDI BIOTHERAPEUTICS INC

0.2458
+0.01195.09%
盤後0.25440.0086+3.50%16:59 EDT
成交量:55.11萬
成交額:13.33萬
市值:781.46萬
市盈率:-0.08
高:0.2500
開:0.2339
低:0.2339
收:0.2339
資料載入中...
2024/04/01

重要事件披露

Form 8-K - Current report
2024/04/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

重要事件披露

Form 8-K - Current report
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/07

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/29

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/01/17

SEC問詢函

Form CORRESP - Correspondence
2024/01/16

SEC問詢函

Form CORRESP - Correspondence
2024/01/16

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]